site map  

 

 

 

 

 

 

 

 

QUESTIONS?

+1 (802) 878-1777

hti@haemtech.com


 

 

 

 

 

 

ORDERING

Human Proteins

Bovine Proteins

Mouse Proteins

Other Species

Inhibitors

Substrates

Antibodies

Sample Collection Tubes

Deficient Plasmas

Assay Kits

Pricing

HOME PAGE

 

 

 

 

 

 

 

 

QUESTIONS?

+1 (802) 878-1777

hti@haemtech.com

Osteocalcin 

AMINO ACID SEQUENCE OF BOVINE OSTEOCALCIN The amino acid sequence of bovine bone osteocalcin. The positions of the g-carboxyglutamic acid residues are indicated by g.

 

PURCHASING AND PRODUCT INFORMATION

 

Catalog Number

HOC-0302

BOC-3020

Description

Human Osteocalcin

 Bovine Osteocalcin

Size

20 µg

100 µg

Formulation

20 mM Tris, 150 mM NaCl, pH 7.4

50% glycerol/H2O (v/v)

Storage

-80oC aqueous; -20oC glycerol

Purity

>95% by SDS-PAGE

Activity Determination

N/A

Shelf Life (properly stored)

12 months

Sample Gel Information:

Gel: Novex 4-12% Bis-Tris

Load: Bovine osteocalcin, 1 µg per lane

Buffer: MOPS

Standard: SeeBluePlus 2; Myosin (191 kDa), Phosphorylase B (97 kDa), BSA (64 kDa), Glutamic Dehydrogenase (51 kDa), Alcohol Dehydrogenase (39 kDa), Carbonic Anhydrase (28 kDa), Myoglobin Red (19 kDa), Lysozyme (14 kDa)

 

U.S. Pricing

Product inquiry

SAMPLE DATA SHEET

ORDER NOW!

 

Overview of Osteocalcin

Osteocalcin, also known as Bone-Gla-Protein (BGP), is a single chain (Mr=5800) vitamin K dependent protein produced by osteoblasts and found in high concentrations in bone (1-4). Post-translational modification by a vitamin K dependent carboxylase produces three g-carboxyglutamic acid residues at positions 17, 21 and 24. The mature protein contains 49 amino acids and a single intrachain disulfide bond joining Cys23 to Cys29. The secondary structure is highly calcium dependent and contains 14% α-helix, 20% β-sheet and 67% random form in the presence of calcium, and 1% α-helix, 20% β-sheet and 79% random form in the absence of calcium (4).

BGP binds to phospholipid vesicles in the presence of calcium ions (Kd=6 x 10-6 M) (5). BGP also binds hydroxyapatite and is an efficient inhibitor of hydroxyapatite seeded crystal growth, suggesting a regulatory role in bone mineralization (6). Although the fundamental role of BGP in vivo remains elusive, in vitro experimentation suggests roles in both bone resorption and bone formation. BGP has been shown to function as a chemo-attractant in an in vitro macrophage mediated bone resorption system. The serum concentration of BGP has been linked to bone formation rates, and BGP levels are currently used in research assessment of osteoporosis and other metabolic bone disease states (7). 

Osteocalcin is prepared from bovine bone generally as described by Price et al. (1). This involves demineralization in EDTA, size exclusion and ion exchange chromatography. The purified protein is supplied 50 % (vol/vol) glycerol/0.01 M Tris, 0.075 M NaCl, pH 7.4, and should be stored at -20°C. Human osteocalcin is prepared from extracts of acid-demineralized bone, using immunoaffinity chromatography. The human protein is supplied in 0.02 M Tris, 0.15 M NaCl, 2 mM CaCl2, pH 7.4 and should be stored at -80°C. Purity is determined by SDS-PAGE. 

Properties of Osteocalcin

Localization: Bone, plasma
Mode of action: Unknown
Molecular weight: 5,800 (1)
Extinction coefficient:
E
1 %
1 c m, 280 nm
= 13.3 (7)
Isoelectric point: 4.0-4.5 (8)
Structure: Single chain, one intrachain disulfide bond, Cys 23-29.
Percent carbohydrate: 0 %
Post translational modifications: Three gla residues, 17, 21, 24

PURCHASING AND PRODUCT INFORMATION

 

Catalog Number

HOC-0302

BOC-3020

Description

Human Osteocalcin

 Bovine Osteocalcin

Size

20 µg

100 µg

Formulation

20 mM Tris, 150 mM NaCl, pH 7.4

50% glycerol/H2O (v/v)

Storage

-80oC aqueous; -20oC glycerol

Purity

>95% by SDS-PAGE

Activity Determination

N/A

Shelf Life (properly stored)

12 months

U.S. Pricing

Product inquiry

SAMPLE DATA SHEET

ORDER NOW!

References 

1. Price, P.A., et al., in Bone and Mineral Research, Vol. 1, ed. Peck, W., pp. 157-190, Ansterdam: Escerpta Medica (1983). 
2. Hauschka, P.V., et al., Proc. Natl. Acad. Sci., USA, 73, 1447 (1975). 
3. Gundberg, C.M., et al., Methods Enzymol., 107, 516 (1984). 
4. Delmas, P.D., et al., Biochemistry, 23, 4720 (1984). 
5. Gendreau, M.A., et al., J. Biol. Chem., 264, 6972 (1989). 
6. Romberg, R.W., et al., Biochemistry, 25, 1176 (1986). 
7. Tracy, R.P., et al., J. Bone Min. Res., 5, 451 (1990). 

 

PRODUCTS ORDERING SERVICES ABOUT US TECH NOTES CONTACT

 

© 2009 Haematologic Technologies, Inc. All Rights Reservedspacer